VAI is a biomedical research, K–12 & graduate education organization. At VAI, scientists study cancer, Parkinson’s, metabolic disorders and other diseases.
Please join us in congratulating Drs. Ellen Stirtz, April Rickle, Sofia leleva, Thomas Goralski and Svetlana Djirackor, who recently earned their Ph.D.s in molecular and cellular biology from Van Andel Institute Graduate School.
We are excited to partner with GVSU to help strengthen West Michigan’s position as a hub for advanced computing, biomedical research and healthcare innovation.
Van Andel Institute and Grand Valley State University are partnering to advance artificial intelligence-driven biomedical research as part of GVSU’s recently approved Ph.D. in Computing.
https://t.co/FUuFruiNjL
We’re hiring a Postdoc in the Henderson Lab @ Van Andel Institute!
Join our team studying neurodegenerative disease across scales (molecular → circuits). Flexible, high-impact projects and strong mentorship.
Apply: https://t.co/QJFXnmLiIy
Please share!
We are excited to recognize renowned scientist Glenda Halliday, Ph.D., as the recipient of the 2026 Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research!
VAI & @WUR scientists used a CRISPR variant to distinguish tumor DNA from healthy DNA by targeting chemical differences present in cancer cells. Published in @Nature, the study is a promising step toward cancer therapy that targets tumor cells with high precision.
What’s on the horizon in Parkinson’s disease research? In honor of #ParkinsonsAwarenessMonth, VAI’s Dr. Darren Moore highlights five areas to watch for breakthroughs in Parkinson’s research.
A new discovery from VAI scientists shows that a key energy enzyme in tuberculosis-causing bacteria is structured in an unexpected way, which may help it adapt to stress and survive. The findings point toward new ways to make treatments more effective. #WorldTBDay2026
Can a chronic stomach infection influence #Parkinsons disease risk? Recent findings by VAI’s @MXHend and colleagues reveal how infection by the H. pylori bacterium may influence the risk and progression of Parkinson’s.
Drug-resistant fungal infections like Candida auris and Cryptococcus neoformans are on the rise. Recently, a team of scientists from VAI and @McMasterU identified a natural substance that may help a group of low-toxicity antifungal drugs work better.
In 2025, VAI continued to build scientific momentum and drive discoveries that deepen our understanding of human health. Check out our year of research highlights! https://t.co/TSzleFpD4x
Modestly limiting calories promotes the formation of ketones, which act as “fuel” for T cells, reports a study by @DrRGJonesLab & colleagues. The findings pave the way for developing dietary strategies to boost the effects of cancer immunotherapies.
https://t.co/seVm40qBHS
VAI & @CureParkinsonsT are thrilled to announce that we have renewed a funding agreement to support the International Linked Clinical Trials Program, the world’s largest drug repurposing clinical trial initiative for #Parkinsons disease.
https://t.co/7Ss0m4yigO